earnings
CL
NASDAQ · CLNN
Clene Inc.
Healthcare · Biotechnology
$4.14
Down-$0.05 (-1.19%)
Updated Aug 15, 2026, 3:14 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 64.85M
- P/E ratio
- -2.23
- Dividend yield
- 0.00%
- 52-week range
- $3.96 – $8.67
- Volume
- 58.96K
- Avg. volume
- 192.2K
Price performance
CLNN price history
1M range · 21 trading sessions · Daily adjusted prices
CLNN closed at $4.14 after 21 trading sessions, down 30.07% for the selected period.
- Last close
- $4.14
- Period change
- -30.07%
- Period low
- $4.07
- Period high
- $5.92
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $4.16 | $4.25 | $4.10 | $4.14 | 58.96K |
| Aug 13, 2026 | $4.15 | $4.22 | $4.01 | $4.19 | 71.84K |
| Aug 12, 2026 | $4.38 | $4.4551 | $3.955 | $4.07 | 166.06K |
| Aug 11, 2026 | $5.06 | $5.11 | $4.35 | $4.37 | 265.76K |
| Aug 10, 2026 | $5.30 | $5.35 | $4.14 | $5.16 | 300.96K |
| Aug 7, 2026 | $5.37 | $5.5693 | $5.2686 | $5.28 | 50.4K |
| Aug 6, 2026 | $5.40 | $5.5559 | $5.31 | $5.34 | 22.21K |
| Aug 5, 2026 | $5.40 | $5.4795 | $5.26 | $5.38 | 46.52K |
| Aug 4, 2026 | $5.33 | $5.415 | $5.23 | $5.28 | 45.98K |
| Aug 3, 2026 | $5.01 | $5.31 | $5.01 | $5.19 | 27.26K |
| Jul 31, 2026 | $5.04 | $5.4272 | $4.94 | $5.015 | 33.75K |
| Jul 30, 2026 | $4.78 | $5.13 | $4.78 | $5.04 | 37.35K |
| Jul 29, 2026 | $4.87 | $5.04 | $4.63 | $4.72 | 140.75K |
| Jul 28, 2026 | $5.40 | $5.40 | $4.89 | $4.99 | 93.04K |
| Jul 27, 2026 | $5.39 | $5.4665 | $5.29 | $5.46 | 28.26K |
| Jul 24, 2026 | $5.50 | $5.50 | $5.31 | $5.39 | 48.26K |
| Jul 23, 2026 | $5.73 | $5.8912 | $5.45 | $5.48 | 85.52K |
| Jul 22, 2026 | $5.89 | $5.9599 | $5.66 | $5.82 | 42.79K |
| Jul 21, 2026 | $5.75 | $5.96 | $5.69 | $5.85 | 72.5K |
| Jul 20, 2026 | $5.85 | $6.0168 | $5.72 | $5.73 | 39.99K |
| Jul 17, 2026 | $5.59 | $6.015 | $5.5701 | $5.92 | 83.17K |
Latest CLNN news
The latest Smart Investors Daily articles mentioning CLNN.
Stock researchResearch & News · Competitors
Loading stock research…

